Anton Berns

Active 1972–2023

137
Papers
35,348
Citations
100
h-index
136
i10-index

Citations

Citations per year for Anton Berns1972: 5 citations1973: 11 citations1974: 5 citations1976: 5 citations1977: 4 citations1980: 3 citations1981: 19 citations1982: 32 citations1983: 25 citations1984: 40 citations1985: 29 citations1986: 12 citations1987: 17 citations1988: 35 citations1989: 48 citations1990: 62 citations1991: 103 citations1992: 99 citations1993: 151 citations1994: 161 citations1995: 246 citations1996: 284 citations1997: 303 citations1998: 281 citations1999: 352 citations2000: 361 citations2001: 333 citations2002: 450 citations2003: 427 citations2004: 414 citations2005: 403 citations2006: 344 citations2007: 387 citations2008: 335 citations2009: 369 citations2010: 343 citations2011: 336 citations2012: 285 citations2013: 285 citations2014: 310 citations2015: 287 citations2016: 270 citations2017: 256 citations2018: 226 citations2019: 682 citations2020: 665 citations2021: 651 citations2022: 532 citations2023: 326 citations2024: 510 citations2025: 251 citations2026: 4 citations1975: no citations, so this year is not shown1978–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,135 citing papers, 35.5% of this breakdownUnited Kingdom: 1,143 citing papers, 7.9% of this breakdownGermany: 956 citing papers, 6.6% of this breakdownNetherlands: 901 citing papers, 6.2% of this breakdownChina: 814 citing papers, 5.6% of this breakdownFrance: 633 citing papers, 4.4% of this breakdownJapan: 568 citing papers, 3.9% of this breakdownCanada: 560 citing papers, 3.9% of this breakdownItaly: 388 citing papers, 2.7% of this breakdownSwitzerland: 350 citing papers, 2.4% of this breakdownSpain: 339 citing papers, 2.4% of this breakdownAustralia: 310 citing papers, 2.1% of this breakdown
0%35.5%Other 16.4%

Fields

  • Medicine44.8%
  • Biochemistry, Genetics and Molecular Biology39.9%
  • Immunology and Microbiology7.8%
  • Neuroscience3.7%
  • Agricultural and Biological Sciences1.4%
  • Engineering0.4%
  • Other2%

Topics

  • Drug Transport and Resistance Mechanisms3.4%
  • Epigenetics and DNA Methylation3.3%
  • Cancer-related Molecular Pathways2.9%
  • Cancer Cells and Metastasis2.1%
  • CRISPR and Genetic Engineering1.9%
  • Immune Cell Function and Interaction1.9%
  • Other84.5%

Coauthors

All papers

Open in search
  1. Induction of medulloblastomas inp53-null mutant mice by somatic inactivation ofRbin the external granular layer cells of the cerebellum

    Authors: , , , , - Genes & Development 2000 cited by 940

  2. Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung

    Authors: , , , , , - Cancer Cell 2011 cited by 549

  3. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

    Authors: , , , , , - Nature Genetics 2001 cited by 1,067

  4. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

    Authors: , , , , , - Cancer Cell 2003 cited by 648

  5. Cells of origin of lung cancers: lessons from mouse studies

    Authors: , , , - Genes & Development 2020 cited by 206

  6. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

    Authors: , , , , , , , , , , , - Cell 1994 cited by 2,288

  7. A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer

    Authors: , , , , , , - Cancer Cell 2011 cited by 386

  8. SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin

    Authors: , , , , , , , , - Cancer Cell 2016 cited by 255

  9. New Approaches to SCLC Therapy: From the Laboratory to the Clinic

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yves Pommier, Vito Quaranta, Neal Ready, Julien Sage, Giorgio V. Scagliotti, Martin L. Sos, Kate D. Sutherland, William D. Travis, Christopher R. Vakoc, Sarah J. Wait, Ignacio I. Wistuba, Kwok‐Kin Wong, Hua Zhang, Jillian B. Daigneault, Jacinta Wiens, Charles M. Rudin, Trudy G. Oliver - Journal of Thoracic Oncology 2020 cited by 176

  10. For better or for worse: the role of Pim oncogenes in tumorigenesis

    Authors: , , - Nature reviews. Cancer 2010 cited by 486

  11. Origins, genetic landscape, and emerging therapies of small cell lung cancer

    Authors: , , - Genes & Development 2015 cited by 259

  12. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1 -mutated basal-like breast cancer

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 479

  13. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Reports 2016 cited by 159

  14. Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

    Authors: , , , , , , , , , , , , , - Cell 1993 cited by 1,471

  15. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis

    Authors: , , , , , , , , , , , , , - Cancer Cell 2006 cited by 594

  16. Chromatin Position Effects Assayed by Thousands of Reporters Integrated in Parallel

    Authors: , , , , , , , , , - Cell 2013 cited by 349

  17. Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 274

  18. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 601

  19. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice

    Authors: , , , , , , , , - Cell Reports 2020 cited by 56

  20. Drugging the addict: non‐oncogene addiction as a target for cancer therapy

    Authors: , , - EMBO Reports 2016 cited by 157

  21. Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , , - Cancer Cell 2016 cited by 117

  22. Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , - Cell Reports 2019 cited by 63

  23. Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease

    Authors: , - Genes & Development 2021 cited by 56

  24. DCC Expression by Neurons Regulates Synaptic Plasticity in the Adult Brain

    Authors: , , , , , , , , , , , , , , , , , - Cell Reports 2013 cited by 148